Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease
Award amount
$254,240Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Infrared Rx, Inc.
- Proposal award date
- 2021-09-30
- Contract end date
- 2023-08-31
- UEI
- WCBQFL361VY1
- Solicitation number
- PA21-345
- Topic code
- R
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring
- Preventing Vascular Complications in Type Diabetes Muscle Metabolic Monitoring
Research funding history
3 SBIR/STTR records share this UEI (2017–2021). Reported award amounts total $1,784,593. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services